Overview
Lipaglyn Tablets contain Saroglitazar, a unique oral medication primarily prescribed for managing diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes mellitus. Saroglitazar is a dual PPAR (peroxisome proliferator-activated receptor) agonist that helps improve insulin sensitivity, reduce blood sugar levels, and normalize lipid profiles by lowering triglycerides and increasing HDL cholesterol.





